Gilead's interferon-free HCV combo approved.
D001562:Benzimidazoles / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D005449:Fluorenes / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects / Q000472:pathogenicity; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D000069474:Sofosbuvir / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D001562:Benzimidazoles; D004338:Drug Combinations; D005449:Fluorenes; C586541:ledipasvir; D007372:Interferons; D000069474:Sofosbuvir